Yibo B. Wu

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms.

Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms.

Journal: Cell transplantation
Published: July 22, 2026

Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Pre-transplant Clostridioides difficile infection predicts subsequent gastrointestinal GVHD and non-relapse mortality after allogeneic hematopoietic stem cell transplantation.

Journal: Cell transplantation
Published: June 13, 2026

Systemic treatment with the ROCK2 inhibitor belumosudil in ocular chronic graft versus host disease.

Systemic treatment with the ROCK2 inhibitor belumosudil in ocular chronic graft versus host disease.

Journal: American journal of ophthalmology
Published: February 24, 2026

Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.

Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.

Journal: Cell transplantation
Published: February 12, 2026

Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial.

Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial.

Journal: Cancer
Published: February 08, 2026

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

Journal: Bone marrow transplantation
Published: November 27, 2025

Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.

Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.

Journal: Bone marrow transplantation
Published: September 01, 2025

NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.

NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.

Journal: Transplantation and cellular therapy
Published: May 17, 2025

Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCT.

Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCT.

Journal: Annals of hematology
Published: April 27, 2025

KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemia.

KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemia.

Journal: Cancer
Published: January 09, 2025

Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1.

Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1.

Journal: Clinical & translational immunology
Published: January 05, 2025

Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysis.

Higher risk of platelet engraftment failure and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T-cell therapy compared to chemotherapy: A propensity score-matched analysis.

Journal: British journal of haematology
Published: December 05, 2024
Showing 1-12 of 35

Last Updated: 09/26/2026